(Q34475699)

2 August 2017

1 reference

title

Role of cyclooxygenase inhibitors for the prevention of colorectal cancer (English)

1 reference

2 August 2017

1 reference

1 reference

Stack E

1

1 reference

PubMed ID

11764529

2 August 2017

DuBois RN

series ordinal

2

1 reference

2 August 2017

1 December 2001

1 reference

Gastroenterology Clinics of North America

2 August 2017

1 reference

2 August 2017

30

1 reference

2 August 2017

1001-1010

1 reference

2 August 2017

4

1 reference

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Prostaglandin receptors: their role in regulating renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Localization of cyclooxygenase-2 in human sporadic colorectal adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Distribution of prostaglandin E receptors in the rat gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Role of intestinal epithelial cells in the host secretory response to infection by invasive bacteria. Bacterial entry induces epithelial prostaglandin h synthase-2 expression and prostaglandin E2 and F2alpha production

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

The peroxisome proliferator-activated receptors: ligands and activators

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Aspirin and the Risk of Colorectal Cancer in Women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Prostaglandin synthase 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Cancer research. Anti-inflammatories inhibit cancer growth--but how?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Cellular distribution of prostanoid EP receptors mRNA in the rat gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

APC mutations occur early during colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Chemoprevention of colon cancer by minor dietary constituents and their synthetic analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

NSAIDs, gastrointestinal injury, and cytoprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Prostaglandin E2 increases growth and motility of colorectal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Colorectal cancer and nonsteroidal anti-inflammatory drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (COX-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Prostaglandin endoperoxide synthase: structure and catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Sulindac for polyposis of the colon.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Sulindac for polyposis of the colon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Inhibitory effect of a prostaglandin E receptor subtype EP(1) selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Comparison of recombinant cyclooxygenase-2 to native isoforms: aspirin labeling of the active site.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

The role of cyclooxygenases in inflammation, cancer, and development

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Host cyclooxygenase-2 modulates carcinoma growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

Elevated cyclooxygenase-2 levels in Min mouse adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8553%2805%2970225-9

7 January 2021

10.1016/S0889-8553(05)70225-9

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11764529